Boardroom Expansion Detect is actively expanding governance with new Industry veterans Stefan Willemsen and Jeff Hawkins joining the Board of Directors in early 2024, signaling readiness for strategic growth and potential partnerships at scale.

Women’s Health Focus The company centers on women's health diagnostics with a molecular multiplex platform, presenting opportunities to target clinics, hospitals, and direct-to-consumer channels focused on maternal, reproductive, and gynecologic care.

Point-of-Care Momentum Positioned as a point-of-care and home diagnostics provider, Detect offers near-patient testing capabilities that align with telehealth and home-visit care models, enabling partnerships with primary care networks and home health services.

Growth Revenue Signals Reported revenue range of ten to twenty-five million, combined with a mid-size employee base, suggests room for scalable solutions, services, and platform licenses to expand within mid-market healthcare organizations and specialty clinics.

Strategic Alliances Past collaborations and industry ties, including healthcare and defense technology players, imply potential for co-development, integrator partnerships, and channel partnerships with medical device and diagnostic distributors targeting women’s health.